Biotechnology Allogene Therapeutics Unveils Cell Forge 1, a Uniquely Designed Manufacturing Facility to Deliver AlloCAR T(TM) Products April 14, 2022
Biotechnology Biohaven Announces Expanded Patient Access to Nurtec® ODT (rimegepant), Achieving Best-in-Class Commercial Insurance Coverage and Label Update April 14, 2022
Biotechnology Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age April 14, 2022
Biotechnology Lifshitz Law Firm, P.C. Announces Investigations of BioMarin Pharmaceutical Inc. (NASDAQGS: BMRN), On24, Inc. (NYSE: ONTF), Silverback Therapeutics, Inc. (NASDAQ: SBTX), and Selectquote, Inc. (NYSE: SLQT) April 13, 2022
Biotechnology ANTARES PHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ATRS and Encourages Investors to Contact the Firm April 13, 2022
Biotechnology BioMarin to Host First Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, April 27, at 4:30pm ET April 13, 2022
Biotechnology Allogene Therapeutics Publishes Preclinical Data on ALLO-316, an AlloCAR T(TM) Candidate Targeting CD70 for the Treatment of Renal Cell Carcinoma, at AACR’s Annual Meeting and in Cancer Research Journal April 13, 2022
Search
Biotechnology
